HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Anticancer Agents

Anticancer Agents

Anticancer agents encompass a diverse range of therapies designed to combat cancer by targeting specific aspects of tumor growth and metastasis. These agents can include chemotherapy drugs, targeted therapies, immunotherapies, and hormone therapies. Chemotherapy drugs, such as cisplatin and paclitaxel, work by interfering with the cell division process, effectively killing rapidly dividing cancer cells. Targeted therapies, like monoclonal antibodies and small molecule inhibitors, aim to disrupt specific molecules or pathways crucial for cancer cell survival and proliferation. Immunotherapies harness the power of the immune system to recognize and eliminate cancer cells. Hormone therapies are effective against hormone-sensitive cancers by blocking hormone receptors or reducing hormone production. The development of novel anticancer agents continues to revolutionize cancer treatment, offering hope for improved outcomes and enhanced quality of life for patients.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp